Repligen (RGEN) reported quarterly EPS of $0.48, beating the Zacks Consensus Estimate of $0.38 by $0.10, or about 26%. Earnings also improved from $0.39 per share a year ago, indicating modest year-over-year growth. The result is a positive but fairly routine earnings beat that could support the stock modestly.
Repligen (RGEN) reported quarterly EPS of $0.48, beating the Zacks Consensus Estimate of $0.38 by $0.10, or about 26%. Earnings also improved from $0.39 per share a year ago, indicating modest year-over-year growth. The result is a positive but fairly routine earnings beat that could support the stock modestly.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.34
Ticker Sentiment
